INVO Bioscience (INVO) Short Interest Ratio & Short Volume → The Worst is Yet to Come… (From Porter & Company) (Ad) Free INVO Stock Alerts $0.86 -0.04 (-4.44%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO Bioscience Short Interest DataCurrent Short Interest81,300 sharesPrevious Short Interest33,000 sharesChange Vs. Previous Month+146.36%Dollar Volume Sold Short$86,991.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares3,810,000 sharesFloat Size3,770,000 sharesShort Percent of Float2.16%Today's Trading Volume64,544 sharesAverage Trading Volume165,395 sharesToday's Volume Vs. Average39% Short Selling INVO Bioscience ? Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINVO Short Interest Over TimeINVO Days to Cover Over TimeINVO Percentage of Float Shorted Over Time Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. INVO Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202481,300 shares $86,991.00 +146.4%2.2%0 $1.07 4/30/202433,000 shares $33,000.00 +87.5%1.2%0 $1.00 4/15/202417,600 shares $13,499.20 +45.5%0.7%0 $0.77 3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13 3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03 2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15 Get the Latest News and Ratings for INVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. 2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85 1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00 1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05 12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35 12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23 11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87 11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85 10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30 10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69 9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79 9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04 8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51 8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43 7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96 7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18 6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20 6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17 5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25 5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35 10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15 10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24 9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06 9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46 8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97 8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13 7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99 7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96 6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64 6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89 5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98 5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42 4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51 4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88 3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. 3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19 2/28/202269,000 shares $207,690.00 +63.5%N/A1.5 $3.01 2/15/202242,200 shares $127,022.00 -44.2%N/A1 $3.01 1/31/202275,600 shares $240,408.00 -12.7%N/A1.5 $3.18 1/15/202286,600 shares $312,626.00 -1.5%N/A0 $3.61 12/31/202187,900 shares $292,707.00 -26.1%N/A1.8 $3.33 12/15/2021119,000 shares $445,060.00 +104.1%N/A2.3 $3.74 11/30/202158,300 shares $179,564.00 -55.0%N/A1.1 $3.08 11/15/2021129,400 shares $427,020.00 +5.6%N/A2.6 $3.30 10/29/2021122,500 shares $422,625.00 +29.6%N/A2.7 $3.45 10/15/202194,500 shares $375,165.00 -13.6%N/A2.2 $3.97 9/30/2021109,400 shares $356,644.00 -17.3%N/A3 $3.26 9/15/2021132,200 shares $465,344.00 +20.8%1.4%4 $3.52 8/31/2021109,400 shares $421,190.00 -39.5%1.2%2.7 $3.85 8/13/2021180,700 shares $766,168.00 -14.0%1.9%4.3 $4.24 7/30/2021210,100 shares $895,026.00 +11.6%2.3%4.5 $4.26 7/15/2021188,200 shares $767,856.00 -13.4%2.0%3.2 $4.08 6/30/2021217,400 shares $1.01 million +13.3%2.3%3.1 $4.65 6/15/2021191,900 shares $871,226.00 -34.9%2.1%1.6 $4.54 5/28/2021294,800 shares $1.29 million +0.9%3.2%1.4 $4.38 5/14/2021292,200 shares $1.13 million -7.6%3.2%0.2 $3.86 4/30/2021316,100 shares $1.33 million +11.8%3.5%0.2 $4.22 4/15/2021282,700 shares $1.10 million +2.4%N/A0 $3.90 3/31/2021276,100 shares $1.36 million -5.9%3.1%0.1 $4.94 3/15/2021293,400 shares $1.53 million +1,646.4%3.5%0.2 $5.23 2/26/202116,800 shares $54,536.16 -15.6%0.2%0 $3.25 2/12/202119,900 shares $76,217.00 +7.6%0.2%0.3 $3.83 1/29/202118,500 shares $56,980.00 -29.7%0.2%0.3 $3.08 1/15/202126,300 shares $80,478.00 No Change0.3%0.6 $3.06 10/30/202024,000 shares $89,520.00 +220.0%N/A2.5 $3.73 10/15/20207,500 shares $31,091.25 +5.6%N/A0.6 $4.15 9/30/20207,100 shares $26,625.00 No ChangeN/A1.5 $3.75 9/15/20207,100 shares $28,684.00 -1.4%N/A1.2 $4.04 3/13/202028,900 shares $5,780.00 +381.7%N/A0.4 $0.20 2/28/20206,000 shares $1,500.00 +66.7%N/A0.1 $0.25 2/14/20203,600 shares $934.56 -71.2%N/A0 $0.26 1/31/202012,500 shares $3,093.75 -69.1%N/A0.2 $0.25 1/15/202040,400 shares $8,484.00 +4,388.9%N/A0.6 $0.21 12/31/2019900 shares $192.15 +12.5%N/A0 $0.21 INVO Short Interest - Frequently Asked Questions What is INVO Bioscience's current short interest? Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 81,300 shares of INVO short. 2.16% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest. What is a good short interest percentage for INVO Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.16% of INVO Bioscience's floating shares are currently sold short. Is INVO Bioscience's short interest increasing or decreasing? INVO Bioscience saw a increase in short interest in May. As of May 15th, there was short interest totaling 81,300 shares, an increase of 146.4% from the previous total of 33,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INVO Bioscience's float size? INVO Bioscience currently has issued a total of 3,810,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 3,770,000 shares. How does INVO Bioscience's short interest compare to its competitors? 2.16% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to INVO Bioscience: NEXGEL, Inc. (0.44%), Plus Therapeutics, Inc. (2.89%), GlucoTrack, Inc. (0.04%), Biotricity, Inc. (5.91%), PetVivo Holdings, Inc. (1.49%), Sharps Technology, Inc. (0.58%), NeuroMetrix, Inc. (0.87%), Intelligent Bio Solutions Inc. (2.54%), Vivos Therapeutics, Inc. (1.55%), Vapotherm, Inc. (9.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short INVO Bioscience stock? Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INVO Bioscience? A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further. How often is INVO Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NXGL Short Interest PSTV Short Interest GCTK Short Interest BTCY Short Interest PETV Short Interest STSS Short Interest NURO Short Interest INBS Short Interest VVOS Short Interest VAPO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.